Public Health

How Is HIV-1 CRF119_0107 Spreading in Nanjing, China?
Clinical & Pharma How Is HIV-1 CRF119_0107 Spreading in Nanjing, China?

In the bustling economic hub of Nanjing, China, located in the heart of the Yangtze River Delta, a pressing public health challenge has emerged with the rapid spread of HIV-1 CRF119_0107, a second-generation recombinant strain derived from CRF01_AE and CRF07_BC. This variant has climbed to become

Cuba's Hidden Crisis: Multiple Mosquito-Borne Viruses Surge
Clinical & Pharma Cuba's Hidden Crisis: Multiple Mosquito-Borne Viruses Surge

In a tropical nation renowned for its vibrant culture and storied history, a silent and deadly health emergency is unfolding as Cuba grapples with the simultaneous spread of three mosquito-borne viruses—dengue, chikungunya, and Oropouche. This alarming convergence, termed "combined arboviral

Cancer Lobbyists Unite to Overcome Political Divides
Clinical & Pharma Cancer Lobbyists Unite to Overcome Political Divides

Today, we’re speaking with James Maitland, a renowned expert in robotics and IoT applications in medicine, who brings a unique perspective to the intersection of technology and healthcare. With a deep passion for improving patient outcomes through innovation, James has been following the impactful

Neuroblastoma in Spain: Stable Rates, Rising Survival Over 22 Years
Clinical & Pharma Neuroblastoma in Spain: Stable Rates, Rising Survival Over 22 Years

In a groundbreaking examination spanning over two decades, a comprehensive study conducted from 2000 to 2021 has unveiled critical insights into the landscape of neuroblastoma among children in Spain, focusing on those under 15 years of age. This pediatric cancer, recognized as the most common

How Are Trump Funding Cuts Impacting UC Medical Research?
Clinical & Pharma How Are Trump Funding Cuts Impacting UC Medical Research?

In the heart of California, where innovation often leads the charge against life-threatening diseases, a chilling uncertainty grips the University of California (UC) medical research community as federal funding, the very lifeline of groundbreaking studies at campuses like UCLA, has been frozen by

Can Geriatrics Training Survive Funding Uncertainty?
Clinical & Pharma Can Geriatrics Training Survive Funding Uncertainty?

I'm thrilled to sit down with James Maitland, a renowned expert in geriatrics and healthcare policy, whose extensive work has shaped innovative approaches to training healthcare providers for an aging population. With a deep understanding of programs like the Geriatrics Workforce Enhancement

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later